792 related articles for article (PubMed ID: 18396794)
1. Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency.
La Manna G; Pancaldi L; Dalmastri V; Cuna V; Capecchi A; Comai G; Persici E; Bacchi G; Cianciolo G; Lombardi A; Marrozzini C; Colì L; Stefoni S
In Vivo; 2008; 22(1):123-9. PubMed ID: 18396794
[TBL] [Abstract][Full Text] [Related]
2. Continuous veno-venous hemofiltration for the treatment of contrast-induced acute renal failure after percutaneous coronary interventions.
Marenzi G; Bartorelli AL; Lauri G; Assanelli E; Grazi M; Campodonico J; Marana I
Catheter Cardiovasc Interv; 2003 Jan; 58(1):59-64. PubMed ID: 12508197
[TBL] [Abstract][Full Text] [Related]
3. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
Spargias K; Alexopoulos E; Kyrzopoulos S; Iokovis P; Greenwood DC; Manginas A; Voudris V; Pavlides G; Buller CE; Kremastinos D; Cokkinos DV
Circulation; 2004 Nov; 110(18):2837-42. PubMed ID: 15492300
[TBL] [Abstract][Full Text] [Related]
4. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
Nyman U; Björk J; Aspelin P; Marenzi G
Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
[TBL] [Abstract][Full Text] [Related]
5. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.
Marenzi G; Marana I; Lauri G; Assanelli E; Grazi M; Campodonico J; Trabattoni D; Fabbiocchi F; Montorsi P; Bartorelli AL
N Engl J Med; 2003 Oct; 349(14):1333-40. PubMed ID: 14523141
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.
Marenzi G; Lauri G; Campodonico J; Marana I; Assanelli E; De Metrio M; Grazi M; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
Am J Med; 2006 Feb; 119(2):155-62. PubMed ID: 16443418
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of continuous veno-venous hemofiltration for the treatment of cardiogenic shock in conjunction with acute renal failure after cardiac surgery.
Vidal S; Richebé P; Barandon L; Calderon J; Tafer N; Pouquet O; Fournet N; Janvier G
Eur J Cardiothorac Surg; 2009 Sep; 36(3):572-9. PubMed ID: 19482487
[TBL] [Abstract][Full Text] [Related]
8. Continuous veno-venous hemofiltration in Bhumibol Adulyadej Hospital.
Chuasuwan A; Gojaseni P; Chittinandana A
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S86-97. PubMed ID: 17044459
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
[TBL] [Abstract][Full Text] [Related]
11. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention.
Conen D; Buerkle G; Perruchoud AP; Buettner HJ; Mueller C
Int J Cardiol; 2006 Jun; 110(2):237-41. PubMed ID: 16298441
[TBL] [Abstract][Full Text] [Related]
12. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure.
Elahi MM; Lim MY; Joseph RN; Dhannapuneni RR; Spyt TJ
Eur J Cardiothorac Surg; 2004 Nov; 26(5):1027-31. PubMed ID: 15519198
[TBL] [Abstract][Full Text] [Related]
13. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
Spargias K; Adreanides E; Demerouti E; Gkouziouta A; Manginas A; Pavlides G; Voudris V; Cokkinos DV
Circulation; 2009 Nov; 120(18):1793-9. PubMed ID: 19841299
[TBL] [Abstract][Full Text] [Related]
14. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
[TBL] [Abstract][Full Text] [Related]
15. Can continuous venovenous hemofiltration prevent contrast-agent induced nephropathy in patients with advanced chronic kidney disease after coronary angiography?
Ghani AA; Hussain N; Al Helal B
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):54-60. PubMed ID: 21196613
[TBL] [Abstract][Full Text] [Related]
16. Hemofiltration in the prevention of radiocontrast agent induced nephropathy.
Marenzi G; Bartorelli AL
Minerva Anestesiol; 2004 Apr; 70(4):189-91. PubMed ID: 15173694
[TBL] [Abstract][Full Text] [Related]
17. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Xinwei J; Xianghua F; Jing Z; Xinshun G; Ling X; Weize F; Guozhen H; Yunfa J; Weili W; Shiqiang L
Am J Cardiol; 2009 Aug; 104(4):519-24. PubMed ID: 19660605
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.
Marenzi G; Assanelli E; Marana I; Lauri G; Campodonico J; Grazi M; De Metrio M; Galli S; Fabbiocchi F; Montorsi P; Veglia F; Bartorelli AL
N Engl J Med; 2006 Jun; 354(26):2773-82. PubMed ID: 16807414
[TBL] [Abstract][Full Text] [Related]
19. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
Maioli M; Toso A; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Bellandi F
J Am Coll Cardiol; 2008 Aug; 52(8):599-604. PubMed ID: 18702961
[TBL] [Abstract][Full Text] [Related]
20. Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiography.
Madsen TE; Pearson RR; Muhlestein JB; Lappé DL; Bair TL; Horne BD; Anderson JL;
Crit Pathw Cardiol; 2009 Dec; 8(4):167-71. PubMed ID: 19952552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]